Advertisement

Topics

STAT Plus: Just how badly did Teva misstep? Here’s what the wags say

12:14 EDT 4 Aug 2017 | STAT

Teva missed earnings estimates, lowered profit guidance, cut its dividend by 75 percent, plans to cut 1,000 jobs, close 15 plants, and needs a new CEO.

Original Article: STAT Plus: Just how badly did Teva misstep? Here’s what the wags say

NEXT ARTICLE

More From BioPortfolio on "STAT Plus: Just how badly did Teva misstep? Here’s what the wags say"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...